Western PharmacoEconomics and Outcomes Research Conference
AGENDA
Date: 04/02/21
Meeting Type: Zoom
| TIMINGS | EVENT |
|---|---|
| 8:30am-8:45am | Welcome and Opening Remarks – Diana Brixner, RPh, PhD, FAMCP |
| 8:45am-9:30am |
Session I – "Reflections on the Success of Pharmacoeconomics: Will It Prepare US for the Future? "" Moderator: Diana Brixner, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy, University of Utah Keynote Speaker: Michael Drummond, PhD Professor, Centre for Health Economics, University of York |
| 9:30am-10:15am |
Panel: "How to Pay for Expensive Therapies – What Evidence Do We Need?"" Moderator: Joseph Biskupiak, PhD, MBA University of Utah Speakers: 1. Ron Akehurst, BSc (Econ)(London), DSc, Hon MFPH Chairman of BresMed and Professor Emeritus, University of Sheffield in the School of Health and Related Research (ScHARR) 2. Daniel Malone, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy, University of Utah |
| 10:15am - 10:25am |
Break |
| 10:25am - 11:45am |
Podium Presentation - Session I – (20 min each) Moderator: Karen Rascati, PhD Speakers: 10:25am-10:45am- Jagadeswara Rao Earla University of Houston, TX "Effect Of Different Inverse Probability Treatment Weights (Iptw) On Adherence Trajectories Between Oral Fingolimod And Injectable Disease Modifying Agents Inmultiple Sclerosis" 10:45am-11:05am- Katia Hannah Universtiy of Colorado "Eliciting Patient Preferences for Continuous Glucose Monitoring Devices in Type 1 Diabetes" 11:05am-11:25am- Alex Watanabe Universtiy of Utah "Development and Analysis of a Novel Digital Health App Designed for Cystic Fibrosis" 11:25am-11:45pm- Samuel Crawford University of Southern California "Estimating The Value Of Nursing Time To Reduce Costs And Increase Quality Of Pressure Injury Prevention In Nursing Homes: A Cost-Effectiveness Analysis Of The “Team-Up” Clinical Trial " |
| 11:45am-12:15pm |
Lunch |
| 12:15pm-1:15pm |
Podium Presentation - Session II – (20 min each) Beth Devine, PharmD, PhD, Professor The CHOICE Institute Speakers: 12:55pm-12:35pm- Vanessa Paul Patterson University of Colorado Anschutz Medical Campus "Cost-Effectiveness Analysis Of Pembrolizumab Monotherapy Versus Platinum-Based Chemotherapy For First-Line Treatment Of Programmed Death Ligand-1 Expressing, Locally Advanced Non-Small-Cell Lung Cancer In The United States" 12:35pm-12:55pm- Tingting Qu BresMed America Inc "Review And Comparison Of Overall Survival Extrapolation In Health Technology Assessments For Chimeric Antigen Receptor T-Cell Therapies(Car-Ts)"" 12:55pm-1:15pm- Eunice Kim University of Washigton Elements of Value for Gene Therapy: A Systematic Review |
| 1:15pm - 1:20pm |
Break |
| 1:20pm - 2:05pm |
Session II "Biosimilars in the US: the current state of affairs, barriers to utilization, and real-world research efforts to support treatment and coverage decisions" Moderator: Brett McQueen, PhD Assistant Professor, University of Colorado Speaker: Cate Lockhart, PharmD, PhD Executive Director, Biologics and Biosimilars Collective Intelligence Consortium |
| 2:15pm-3:35pm |
Session III - Poster Session with Authors & Refreshments – virtually Room #1: Moderator: Dan Malone Room #2: Moderator: Diana Brixner Room #3: Moderator: Joe Biskupiak Room #4: Moderator: Nathorn Chaiyakunapruk |
| 3:35pm - 3:45pm |
Break |
| 3:45pm - 4:45pm |
Session IV - Career Panel |
|
4:45pm - 5:00pm |
Closing Remarks - Diana Brixner, RPh, PhD, FAMCP |